California objects to 23andMe sale to former CEO, says it would skirt state privacy law
By Ron Leuty,
San Francisco Business Times
| 06. 16. 2025
23andMe's two-step sale to a nonprofit led by former CEO Anne Wojcicki is nothing more than a dance around California's genetic privacy law, state Attorney General Rob Bonta said in a filing late Monday, one day before a judge will review the deal.
In an objection filed in U.S. Bankruptcy Court in St. Louis, Bonta's team said the proposed structure of 23andMe's sale to a nonprofit formed by Wojcicki skirts a 2021 state law that would require consumers give their "separate and express" consent before their genetic data and biological samples are transferred or disclosed.
More than 20 states have opposed the sale process due to concerns that consumers' genetic information and other private data would be exposed to uses they didn't agree to when signing up for 23andMe's service. In 23andMe's home state of California, the Genetic Information Privacy Act of 2021 should empower consumers to give proactive approval to transfer their data, the filing states.
23andMe doesn't dispute that the law applies, according to the filing, but fears that compliance would be "too costly" because many Californians would...
Related Articles
By Annika Inampudi, Science | 07.10.2025
Before a baby in the United States reaches a few days old, doctors will run biochemical tests on a few drops of their blood to catch certain genetic diseases that need immediate care to prevent brain damage or other serious...
By Geoffrey A. Fowler, The Washington Post | 07.17.2025
Nearly 2 million people protected their privacy by deleting their DNA from 23andMe after it declared bankruptcy in March. Now it’s back with the same person in charge — and I still don’t trust it.
Nor do the attorneys general...
By Elizabeth Dwoskin and Yeganeh Torbati, The Washington Post | 07.16.2025
A group of well-heeled, 30-something women sat down to dinner last spring at a table set with pregnancy-friendly mocktails and orchids, ready to hear a talk about how to optimize their offspring.
Noor Siddiqui, the founder of an embryo-screening start-up...
By Suzanne O'Sullivan, New Scientist | 07.09.2025
Rare diseases are often hard to spot. They can evade detection until irreversible organ damage or disability has already set in. Last month, in the hope of preventing just this type of harm, the UK’s health secretary, Wes Streeting, announced...
